- Home
- EBON vs SONN Comparison
EBON vs SONN Comparison
Compare EBON & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBON
- SONN
- Stock Information
- Founded
- EBON 2010
- SONN N/A
- Country
- EBON China
- SONN United States
- Employees
- EBON N/A
- SONN N/A
- Industry
- EBON Semiconductors
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- EBON Technology
- SONN Health Care
- Exchange
- EBON Nasdaq
- SONN Nasdaq
- Market Cap
- EBON 24.4M
- SONN 21.4M
- IPO Year
- EBON 2020
- SONN N/A
- Fundamental
- Price
- EBON $4.95
- SONN $5.54
- Analyst Decision
- EBON
- SONN Strong Buy
- Analyst Count
- EBON 0
- SONN 1
- Target Price
- EBON N/A
- SONN $20.00
- AVG Volume (30 Days)
- EBON 10.5K
- SONN 960.3K
- Earning Date
- EBON 08-15-2025
- SONN 08-13-2025
- Dividend Yield
- EBON N/A
- SONN N/A
- EPS Growth
- EBON N/A
- SONN N/A
- EPS
- EBON N/A
- SONN N/A
- Revenue
- EBON $7,337,066.00
- SONN $1,000,000.00
- Revenue This Year
- EBON N/A
- SONN $5,376.22
- Revenue Next Year
- EBON N/A
- SONN N/A
- P/E Ratio
- EBON N/A
- SONN N/A
- Revenue Growth
- EBON 104.28
- SONN 1689.52
- 52 Week Low
- EBON $3.00
- SONN $1.08
- 52 Week High
- EBON $10.94
- SONN $19.30
- Technical
- Relative Strength Index (RSI)
- EBON 69.71
- SONN 68.98
- Support Level
- EBON $4.01
- SONN $2.71
- Resistance Level
- EBON $4.20
- SONN $6.65
- Average True Range (ATR)
- EBON 0.32
- SONN 0.67
- MACD
- EBON 0.09
- SONN 0.28
- Stochastic Oscillator
- EBON 92.19
- SONN 71.83
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.